Dimensional Fund Advisors LP Dia Medica Therapeutics Inc. Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 19,339 shares of DMAC stock, worth $114,486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,339
Previous 16,959
14.03%
Holding current value
$114,486
Previous $71,000
43.66%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DMAC
# of Institutions
49Shares Held
5.27MCall Options Held
8.9KPut Options Held
200-
Vanguard Group Inc Valley Forge, PA1.24MShares$7.35 Million0.0% of portfolio
-
First Manhattan CO New York, NY839KShares$4.97 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX515KShares$3.05 Million6.41% of portfolio
-
Bleichroeder LP New York, NY382KShares$2.26 Million0.63% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA375KShares$2.22 Million0.0% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $157M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...